BN 02/21 19:02 Valeant Said to Agree to Buy Salix for $158 a Share in Cash
BN 02/21 18:54 *VALEANT SAID TO AGREE TO BUY SALIX FOR $158 A SHARE IN CASH
BN 02/21 18:54 *VALEANT SAID TO AGREE TO BUY SALIX FOR $158 A SHARE IN CASH
Valeant Said to Agree to Buy Salix for $158 a Share in Cash
2015-02-21 19:04:27.769 GMT
By Ed Hammond and Dan Hart
(Bloomberg) -- Salix Pharma purchase valued at ~$10.1b,
person familiar with the matter said.
Link to Company News:{SLXP US <Equity> CN <GO>}
Link to Company News:{VRX CN <Equity> CN <GO>}
For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}
To contact the reporter on this story:
Dan Hart in Washington at +1-202-624-1870 or
dahart@bloomberg.net
To contact the editor responsible for this story:
Mike Millard at +1-206-262-4142 or
mmillard2@bloomberg.net
2015-02-21 19:04:27.769 GMT
By Ed Hammond and Dan Hart
(Bloomberg) -- Salix Pharma purchase valued at ~$10.1b,
person familiar with the matter said.
Link to Company News:{SLXP US <Equity> CN <GO>}
Link to Company News:{VRX CN <Equity> CN <GO>}
For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}
To contact the reporter on this story:
Dan Hart in Washington at +1-202-624-1870 or
dahart@bloomberg.net
To contact the editor responsible for this story:
Mike Millard at +1-206-262-4142 or
mmillard2@bloomberg.net